arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

iSpecimen Inc.

ISPC
$0.85 ▲ +0.02 (+2.29%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
7 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
7
Health
Poor
Bearish
auto_awesome

Analytical Summary

iSpecimen Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $3.9M
Dividend Yield —
Revenue Growth -79.2% ↘
Op. Margin -465.4% ↘
ROIC -229.7% ↗
FCF / Share $-0.92 ↗
Trailing P/E —
Price / Book 2.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.93M
↓ -79.2% —
Net Income Profit after all expenses
$-10.49M
↑ +16.1% —
Operating Margin Operating profit as % of sales
-465.4%
↓ -239.7% 0th
FCF / Share Free cash flow per share
$-0.92
↑ +92.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Financial Health ↓
2
Cash Quality ↓
36

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters